BNT162b5 - CISMeF

Preferred Label : BNT162b5;

MeSH definition : A combined mRNA vaccine, developed by Pfizer and BioNTech against SARS-CoV-2 with a mixture of the original strain of SARS-CoV-2 and BA.4 and BA.5 lineages of the omicron variant of SARS-CoV-2.;

MeSH Hyperonym : COVID 19 Vaccine Pfizer BioNTech, Bivalent; Pfizer-BioNTech COVID-19 Vaccine, Bivalent; Pfizer BioNTech COVID 19 Vaccine, Bivalent;

Details

Origin ID

D000096106;

UMLS CUI

C5828320;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- BNT162b5 [MeSH concept]
- COVID-19 Vaccine Pfizer-BioNTech, Bivalent [MeSH concept]
Semantic type(s)
- Immunologic Factor [UMLS semantic type]
- Nucleic Acid, Nucleoside, or Nucleotide [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients